Pittenger & Anderson Inc’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-74
| Closed | -$4.45K | – | 480 |
|
|
2023
Q1 | $4.45K | Hold |
74
| – | – | ﹤0.01% | 391 |
|
|
2022
Q4 | $5.43K | Hold |
74
| – | – | ﹤0.01% | 369 |
|
|
2022
Q3 | $6K | Buy |
74
+14
| +23% | +$1.14K | ﹤0.01% | 368 |
|
|
2022
Q2 | $4K | Hold |
60
| – | – | ﹤0.01% | 391 |
|
|
2022
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 383 |
|
|
2021
Q4 | $5K | Buy |
60
+19
| +46% | +$1.58K | ﹤0.01% | 397 |
|
|
2021
Q3 | $5K | Buy |
41
+6
| +17% | +$732 | ﹤0.01% | 394 |
|
|
2021
Q2 | $8K | Buy |
35
+10
| +40% | +$2.29K | ﹤0.01% | 336 |
|
|
2021
Q1 | $3K | Hold |
25
| – | – | ﹤0.01% | 365 |
|
|
2020
Q4 | $4K | Hold |
25
| – | – | ﹤0.01% | 338 |
|
|
2020
Q3 | $3K | Buy |
25
+6
| +32% | +$720 | ﹤0.01% | 335 |
|
|
2020
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 353 |
|
|
2020
Q1 | $1K | Buy |
19
+8
| +73% | +$421 | ﹤0.01% | 346 |
|
|
2019
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 361 |
|
|
2019
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 356 |
|